Sarah Romano - Chief Financial Officer at GridAI Technologies Corp.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
GRDX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Sarah Romano since 04 Aug 2025

Reported holdings for Sarah Romano in GridAI Technologies Corp.

Form 4 holding Chief Financial Officer

Entero Therapeutics, Inc.

Security class
Common Stock
Shares / value
17,287
Estimated value
$11,064
Report date
06 Jan 2025
Price
$0.6400
Ownership
Direct

Transaction history for Sarah Romano in GridAI Technologies Corp.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .